|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09997 KANGJI MEDICAL
Nominal 
5.900 +0.110 (+1.900%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 458,413 | 13.584% | 403,589 | 332,321 | 318,124 | 212,587 |
| Cost of Sales | (95,290) | 16.443% | (81,834) | (66,609) | (56,897) | (34,953) |
| Gross Profit | 363,123 | 12.857% | 321,755 | 265,712 | 261,227 | 177,634 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 842 | -- | (1,647) | (639) | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (5,868) | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 327,733 | 20.809% | 271,282 | 194,794 | 234,349 | 113,915 | |
| Taxation | (52,047) | 23.966% | (41,985) | (41,297) | (34,991) | (24,319) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 10,161 | -61.164% | 26,164 | 4,216 | 0 | (8,854) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 285,847 | 11.895% | 255,461 | 157,713 | 199,358 | 80,742 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (62,016) | 49.584% | (41,459) | (25,815) | (14,536) | (3,240) |
| Depreciation & Amortisation | 14,179 | -12.270% | 16,162 | 8,939 | 5,524 | 3,791 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | 24.390 | 11.727% | 21.830 | 12.950 | 16.270 | 11.920 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 1.945 | -- | 2.796 | 2.665 | 2.454 | 2.364 |
| Remarks: | Real time quote last updated: 01/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 285,847,000 |
| %Change | 11.895% |
| EPS / (LPS) | RMB 0.244 |
| NBV Per Share (¥) | RMB 1.945 |